BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10693633)

  • 1. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
    Gale RP; Park RE; Dubois R; Bitran JD; Buzdar A; Hortobagyi G; Jones SE; Lazar GS; Spitzer G; Swain SM; Vaughn CB; Vogel CE; Martino S
    Clin Transplant; 2000 Feb; 14(1):32-41. PubMed ID: 10693633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
    Gale RP; Park RE; Dubois RW; Herzig GP; Hocking WG; Horowitz MM; Keating A; Kempin S; Linker CA; Schiffer CA; Wiernik PH; Weisdorf DJ; Rai KR
    Leuk Res; 1999 Sep; 23(9):817-26. PubMed ID: 10475621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.
    Gale RP; Park RE; Dubois RW; Herzig GP; Hocking WG; Horowitz MM; Keating A; Kempin S; Linker CA; Schiffer CA; Wiernik PH; Weisdorf DJ; Rai KR
    Leuk Res; 1998 Nov; 22(11):973-81. PubMed ID: 9783798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.
    Gale RP; Park RE; Dubois RW; Herzig GP; Hocking WG; Horowitz MM; Keating A; Kempin S; Linker CA; Schiffer CA; Wiernik PH; Weisdorf DJ; Rai KR
    Leuk Res; 1999 Aug; 23(8):709-18. PubMed ID: 10456668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma.
    Gale RP; Park RE; Dubois RW; Anderson KC; Audeh WM; Bergsagel D; Jagannath S; Kyle RA; Oken MM; Perlman M; Rifkin RM; Stone MJ; Durie B
    Leuk Lymphoma; 1999 May; 33(5-6):511-9. PubMed ID: 10342578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma.
    Gale RP; Park RE; Dubois R; Bierman PJ; Fisher RI; Loh KK; Peterson BA; Phillips GL; Portlock CS; Rosenblum D; Armitage JO
    Leuk Lymphoma; 1998 Dec; 32(1-2):139-49. PubMed ID: 10037009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
    Rowlings PA; Williams SF; Antman KH; Fields KK; Fay JW; Reed E; Pelz CJ; Klein JP; Sobocinski KA; Kennedy MJ; Freytes CO; McCarthy PL; Herzig RH; Stadtmauer EA; Lazarus HM; Pecora AL; Bitran JD; Wolff SN; Gale RP; Armitage JO; Vaughan WP; Spitzer G; Horowitz MM
    JAMA; 1999 Oct; 282(14):1335-43. PubMed ID: 10527180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
    Antman KH; Rowlings PA; Vaughan WP; Pelz CJ; Fay JW; Fields KK; Freytes CO; Gale RP; Hillner BE; Holland HK; Kennedy MJ; Klein JP; Lazarus HM; McCarthy PL; Saez R; Spitzer G; Stadtmauer EA; Williams SF; Wolff S; Sobocinski KA; Armitage JO; Horowitz MM
    J Clin Oncol; 1997 May; 15(5):1870-9. PubMed ID: 9164197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
    McGuire WP
    Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation for metastatic breast cancer.
    Saez RA; Selby GB; Slease RB; Epstein RB; Mandanas RA; Confer DL
    J Okla State Med Assoc; 1994 Sep; 87(9):405-10. PubMed ID: 7996314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
    N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy.
    Shah AB; Hartsell WF; Ghalie R; Kaizer H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1433-8. PubMed ID: 7635784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
    Myers SE; Mick R; Williams SF
    Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
    Holland HK; Dix SP; Geller RB; Devine SM; Heffner LT; Connaghan DG; Hillyer CD; Hughes LL; Miller RL; Moore MR; Winton EF; Wingard JR
    J Clin Oncol; 1996 Apr; 14(4):1156-64. PubMed ID: 8648370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry.
    McCarthy P; Hurd D; Rowlings P; Crump M; Gale R; Lazarus H; Vaughan W; Weinberger B; Wiemann M; Freytes C; Cirenza E; Antman K
    Bone Marrow Transplant; 1999 Aug; 24(4):365-8. PubMed ID: 10467324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy for breast cancer.
    Gradishar WJ; Tallman MS; Abrams JS
    Ann Intern Med; 1996 Oct; 125(7):599-604. PubMed ID: 8815759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes.
    Crump M; Goss PE; Prince M; Girouard C
    J Clin Oncol; 1996 Jan; 14(1):66-9. PubMed ID: 8558222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.